Diabetic Shoes Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

 Diabetic footwear with distinct vital components such as raw material and comfort are becoming increasingly popular among diabetes patients worldwide.

They help to reduce the risk of skin damage in diabetic patients with pre-existing diet issues.

The global diabetic shoes market trend is expected to grow at 6.4% CAGR during the forecast period of 2022-2032, opines Future Market Insights (FMI).

The overall demand in the market is driven by increased innovation by major players to offer personalized and attractive diabetic footwear to meet the latest fashion trends, particularly among the female population.

The quality of life of diabetic patients have improved dramatically when they use diabetic shoes on a regular basis.

Adoption of these shoes is also increasing as they are cost-effective with professional care services such as diabetic foot ulcer treatment and amputations.

This aspect is expected to boost the diabetic footwear sales in the coming years. Further, increased demand for unique designs and comfort will benefit the global diabetic shoe market.

Growing awareness for health and easy availability is expected to improve the demand for diabetic shoes.

Additionally, market participants are providing more tailored diabetic shoes as a result of growing awareness among diabetes patients.

Wellness Diabetes, for instance, offers high-quality footwear made of micro cellular polymer that is personalized for patients with calluses, corns, or other foot deformities.

On the back of these aforementioned factors, the global diabetic shoes market is estimated to surpass US$ 14.9 Bn by the end of 2032.

Key Takeaways

  • Dress shoes are predicted to account for the majority of the market in terms of type owing to the increased awareness regarding living a healthy and active lifestyle.
  • In terms of width, the medium width segment is held a significant share of 29.5% in 2021.
  • Based on end user, women are predicted to hold a considerable proportion of the end-user market due to the increased prevalence of diabetes among women
  • Based on patient type, the outpatient category is expected to grow rapidly with a CAGR of 8.3% during the projection period.
  • The U.S. held a noteworthy value share of 67.6% in North America in 2021 owing to the rising prevalence of diabetes in the country.

 Who is winning?

Leading manufacturers of diabetic shoes are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of diabetic shoes globally.

Major players present in the diabetic shoes market are Daifuku, DJO, LLC (Dr. Comfort), Drewshoe, Incorporated, Orthofeet Inc., DARCO International, Inc., Clearwell Mobility Company, Supad, Aetrex Worldwide, Inc., Gravity Defyer Corp., Kinetec Medical Products Ltd, Horng Shin Footwear Co., Watts Footwear, ASICS Corporation, Advance Diabetic Solution, Dr Zen Products, Inc., Sensoria Health among others.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global diabetic shoes market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

The study divulges compelling insights on the diabetic shoes market based on the product type (dress shoes, running shoes, strolling shoes, others) patient type (outpatient & inpatient) end user (men & women) width (narrow, medium, wide and others) and sales channel (direct sales, footwear specialty stores, medical & healthcare centres, online retailers, mono-brand stores & other sales channel) across seven major regions

Global Diabetic Shoes Market By Category

By Product Type:

  • Dress Shoes
  • Running Shoes
  • Strolling Shoes
  • Others

By Patient Type:

  • Outpatient
  • Inpatient

By End User:

  • Men
  • Women

By Width:

  • Narrow
  • Medium
  • Wide
  • Others

By Sales Channel:

  • Direct Sales
  • Footwear Specialty Stores
  • Medical & Healthcare Centres
  • Online Retailers
  • Mono-Brand Stores
  • Other Sales Channel

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

 For More Information @ https://www.futuremarketinsights.com/reports/diabetic-shoes-market 

Comments

Post a Comment

Popular posts from this blog

Mammography Market Demand, Scope and Future Estimation until 2032

  The global  mammography market    is estimated to be worth around  US$ 1.7 Billion  in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around  6.5%  to  9% CAGR  between 2022 and 2032, totaling over  US$ 3.4 Billion  by 2032. Mammography  is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumor. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide. Increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a major impetus to the growth of mammography market. It is one of the most common f...
Read more

Interventional Cardiology Devices Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The  interventional cardiology devices market demand  is expected to grow at an  8.4%  CAGR from  USD 16.4  Billion in 2022 to USD  36.9  Billion by 2032. The fast expansion of the geriatric population and the corresponding increase in the prevalence of coronary artery diseases, the approval of new and sophisticated products, and the growing incidence of diabetes are all driving growth in the interventional cardiology devices market. However, the availability of alternative therapies, as well as product failures and recalls, are the primary factors projected to hinder interventional cardiology devices market growth over the projection period. COVID-19 has had a global influence on every element of the medical device business, including the market for interventional cardiology equipment. Despite the fact that emergency and outpatient treatments are offered in cardiology departments, the number of patient visits to hospitals has decreased dra...
Read more

Cardiac Rehabilitation Market Research, Segmentation, Key Players Analysis & Forecast By 2032

  The  cardiac rehabilitation market share  is likely to expand its roots in the global market at an average CAGR of 6.0% between 2022 and 2032. The market is valued at US$ 2.1 Bn in 2022 and is likely to reach US$ 3.8 Bn by 2032. Previously, the market was thriving at a slightly higher CAGR of 6.5% (2015-2021), ensuring a market size of US$ 2 Billion in 2021. “Growing lifestyle-related diseases like diabetes and cardiovascular strokes along with the technological revolution in the healthcare sector, helping the patients going through heart attack, heart valve surgeries, heart failures.” An unhealthy lifestyle is leading to new heart-related diseases like heart attacks and heart failure. The technologically advanced tools that enable easy surgery processes drive the sales of cardiac rehabilitation systems. These systems help end users with exercises, diet, stress management and training, managing and monitoring the daily progress of the health routine. It is largely consu...
Read more